No major change in vCJD agent strain after secondary transmission via blood transfusion

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Bishop, Matthew T ^a   Ritchie, Diane L ^a   Will, Robert G ^a   Ironside, James W ^a   Head, Mark W ^a   Thomson, Val ^b   Bruce, Moira ^b   Manson, Jean C ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; INFECTION RISK; INOCULATION; MOUSE; NONHUMAN; RISK ASSESSMENT; STRAIN DIFFERENCE; TRANSGENIC MOUSE; VARIANT CREUTZFELDT JAKOB DISEASE; VARIANT CREUTZFELDT JAKOB DISEASE AGENT; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WILD TYPE; ANIMAL; BRAIN; CREUTZFELDT JAKOB DISEASE; DISEASE MODEL; DISEASE TRANSMISSION; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOGENICITY; PATHOLOGY; PRION;

BOVINAE; BOVINE SPONGIFORM ENCEPHALOPATHY PRION; MURINAE; MUS MUSCULUS;

ANIMALS; BLOOD TRANSFUSION; BRAIN; CREUTZFELDT-JAKOB SYNDROME; DISEASE MODELS, ANIMAL; GENETIC VARIATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; PRIONS;

EID: 51449104990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002878     Document Type: Article

References (35)

1. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921-925.
2. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389: 498-501.
3. Andrews NJ, Farrington CP, Ward HJ, Cousens SN, Smith PG, et al. (2003) Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 361: 751-752.
4. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417-421.
5. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG (2006) Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91: 221-230.
6. Zeidler M, Stewart G, Cousens SN, Estibeiro K, Will RG (1997) Codon 129 genotype and new variant CJD. Lancet 350: 668.
7. HPA (2006) New case of blood transfusion-associated variant-CJD. CDR Weekly 16.
8. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, et al. (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368: 2061-2067.
9. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527-529.
10. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, et al. (2006) Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ.
11. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, et al. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203: 733-739.
12. Bishop M, Hart P, Aitchison L, Baybutt H, Plinston C, et. al. (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. The Lancet Neurology 5: 393-398.
13. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356: 999-1000.
14. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, et al. (2002) Transmission of prion diseases by blood transfusion. J Gen Virol 83: 2897-2905.
15. McCutcheon S, Hunter N, Foster JD, Macgregor I, Hornsey V, et al. (2007) Transmission of BSE infection in sheep via blood transfusion. Edinburgh.
16. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, et al. (1997) The same prion strain causes vCJD and BSE. Nature 389: 448-450.
17. Taguchi Y, Mohri S, Ironside JW, Muramoto T, Kitamoto T (2003) Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions. Am J Pathol 163: 2585-2593.
18. Capobianco R, Casalone C, Suardi S, Mangieri M, Miccolo C, et al. (2007) Conversion of the BASE Prion Strain into the BSE Strain: The Origin of BSE? PLoS Pathogens 3: c31.
19. Kong Q, Huang S, Zou W, Vanegas D, Wang M, et al. (2005) Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 25: 7944-7949.
20. Manson JC, Cancellotti E, Hart P, Bishop MT, Barron RM (2006) The transmissible spongiform encephalopathies: emerging and declining epidemics. Biochem Soc Trans 34: 1155-1158.
21. Korth C, Kaneko K, Groth D, Heye N, Telling G, et al. (2003) Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A 100: 4784-4789.
22. Asante EA, Linehan JM, Gowland I, Joiner S, Fox K, et al. (2006) Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A 103: 10759-10764.
23. Bruce ME, McConnell I, Will RG, Ironside JW (2001) Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358: 208-209.
24. Bruce M, Will R, Ironside J, Fraser H (2006) Evidence for a link between variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. In: Hornlimann B, Riesner D, Kretzschmar H, eds. Prions in Humans and Animals Walter de Gruyter. pp 573-578.
25. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, et al. (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: U.K. cases 1991-2002. Ann Neurol 55: 851-859.
26. Cooper JK, Ladhani K, Minor PD (2007) Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays. Vox Sang 92: 302-310.
27. Herzog C, Sales N, Etchegaray N, Charbonnier A, Freire S, et al. (2004) Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 363: 422-428.
28. Baron T (2002) Mouse models of prion disease transmission. Trends Mol Med 8: 495.
29. Bruce M, Chree A, McConnell I, Foster J, Pearson G, et al. (1994) Transmission of bovine spongiform encephalopathy and scrapie to mice - strain variation and the species barrier. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences 343: 405-411.
30. Lasmezas CI, Fournier JG, Nouvel V, Boe H, Marce D, et al. (2001) Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci U S A 98: 4112-4117.
31. Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, et al. (2003) Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 43: 1687-1694.
32. Bartz JC, Kincaid AE, Bessen RA (2003) Rapid prion neuroinvasion following tongue infection. J Virol 77: 583-591.
33. Barron RM, Baybutt H, Tuzi NL, McCormack J, King D, et al. (2005) Polymorphisms at codons 108 and 189 in murine PrP play distinct roles in the control of scrapie incubation time. J Gen Virol 86: 859-868.
34. Fraser H, Dickinson AG (1968) The sequential development of the brain lesion of scrapie in three strains of mice. Journal of Comparative Pathology 78: 301-311.
35. Bruce ME, McConnell I, Fraser H, Dickinson AG (1991) The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72 (Pt 3): 595-603.